Un ANSA Incontra con i ricercatori sulla ricerca di frontiera
Risultati per: Nanotubi di DNA per terapie contro i tumori del cervello
Questo è quello che abbiamo trovato per te
Tumori, l'umanizzazione delle cure fa bene anche ai medici
Cipomo, ‘possibile antidoto contro burnout e aggressioni’
Randomised controlled trial evaluating the impact of different methods of HPV DNA testing for cervical cancer screening in Singapores primary care settings: a study protocol
Introduction
Cervical cancer remains a significant public health concern in Singapore, with current screening rates at 43%, well below the national target of 70%. In 2019, human papillomavirus (HPV) DNA testing was introduced into the national cervical cancer screening programme, but barriers to participation include embarrassment, privacy concerns and discomfort with clinician-sampled tests. Self-sampled HPV DNA testing offers a promising alternative by providing more privacy and convenience. This study aims to evaluate the impact of including self-sampled HPV DNA testing as an alternative to clinician-sampling on screening uptake, clinical outcomes and cost-effectiveness in primary care.
Methods and analysis
This pragmatic, open-label, two-arm randomised controlled trial employs a Zelen design. A total of 650 women aged 30–69 who are due for cervical cancer screening will be recruited from National Healthcare Group Polyclinics in Singapore. Participants will be randomly assigned to either the intervention arm (offering both self-sampling and clinician-sampling) or the usual care arm (clinician-sampling only). The primary outcome is the proportion of participants in each arm detected with high-risk HPV. Secondary outcomes include the proportion of participants in each arm who undergo cervical cancer screening (uptake), are referred for colposcopy and are detected with CIN 2/3 or cervical cancer, as well as cost-effectiveness. Acceptability and feasibility of self-sampling will be evaluated through post-screening questionnaires.
Ethics and dissemination
Ethical approval was granted by the National Healthcare Group Domain Specific Review Board. Study results will be disseminated through peer-reviewed journals, healthcare conferences and shared with policymakers to guide potential inclusion of self-sampling in Singapore’s national cervical cancer screening programme. Findings from this trial will provide crucial evidence for the potential inclusion of self-sampling in Singapore’s national cervical cancer screening programme, which could increase screening rates and improve public health outcomes.
Trial registration number
ClinicalTrials.gov: NCT06528184.
Il Mef boccia l'emendamento per il fondo prevenzione dei tumori al seno
Lo aveva presentato la maggioranza. M5s: ‘Però usano soldi per le armi’
Super-occhio contro i tumori, vede e colpisce in 6 secondi
Al Negrar tecnologia di ultima generazione per la radioterapia, unico in Italia
Nuova arma ultra precisa contro tumori, li colpisce in 6 secondi
All’Irccs Negrar per la radioterapia, tecnologia unica in Italia
Tumori, legame tra bevande zuccherate e cancro orale nelle donne
Studio, una bevanda al giorno aumenta il rischio di 5 volte
Tumori, legame tra bevande zuccherate e cancro orale nelle donne
Studio, una bevanda al giorno aumenta il rischio di 5 volte
Il mistero dell'asse cuore-cervello, svelati i legami
Prima visione d’insieme tra sistema cardiovascolare e nervoso
La dieta mediterranea è una terapia, effetti da cuore a cervello
Prime linee guida da Iss e 20 società scientifiche
Settimana Cervello, in Vallesina screening incontri e natura
Asp Ambito 9 a Jesi per prevenzione malattie neurodegenerative
Scoperto il motore che rende i tumori aggressivi, il primo è quello al pancreas
Studio italiano, la chiave è in una particolare trasformazione delle cellule
Epigenomic pathways from racism to preterm birth: secondary analysis of the Nulliparous Pregnancy Outcomes Study: monitoring Mothers-to-be (nuMoM2b) cohort study in the USA to examine how DNA methylation mediates the relationship between multilevel racism and preterm birth in black women: a study protocol
Introduction
Preterm birth is a significant contributor to pregnancy-related morbidity and mortality, particularly affecting black women. Racism is a key driver of perinatal inequities, but mechanisms remain unclear. Epigenomics research offers promise in understanding how environmental exposures, including racism, influence gene expression and adverse pregnancy outcomes. We present our study protocol describing how we will investigate the interactive effects of individual- and structural-level racism on preterm birth within and across black and white women, characterise the blood-based methylome of black pregnant women and identify whether DNA methylation mediates the association between multilevel racism and preterm birth in black women.
Methods and analysis
We will conduct a secondary analysis of data from 6843 participants in the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be (nuMoM2b), a longitudinal, prospective cohort study (2010–2014). Individual-level racism was collected using the Experiences of Discrimination scale. Structural racism measures include racial residential segregation, income and racial polarisation, political participation, judicial treatment, homeownership and employment. These measures will be calculated using geocoded participant addresses and publicly available census data for black and white populations. Epigenome-wide methylation analyses will be conducted on stored DNA for all enrolled black women using the EPIC 2.0 BeadChip. Preterm birth was determined by abstraction from participant electronic health records. We will determine the joint effects of individual and structural racism on preterm birth, characterise DNA methylation profiles associated with preterm birth among black women and explore the mediating role of DNA methylation in the association between multilevel racism and preterm birth.
Ethics and dissemination
Study procedures were approved by the Columbia University Institutional Review Board (#AAAU0215). This study aims to fill critical knowledge gaps regarding the role of racism and epigenomics in preterm birth among black women.
Urinary DNA Methylation Test for Bladder Cancer Diagnosis
This prospective multicenter study including individuals with hematuria evaluates the performance of a urinary DNA methylation test in identifying patients with high-grade or invasive bladder cancer.
Tumori: in 10 anni in Italia 500 studi di fase I, in Spagna 960
Italia dietro anche a Gb, Germania e Francia. Network contro gap
Cresce Mnesys, è la più grande rete Ue di ricerca sul cervello
Il progetto finanziato dal Pnrr conta 90 centri e 800 scienziati